Drug discovery is a multi-billion dollar industry and chemists play an integral role in many points on the drug discovery roadmap. To ensure the best possible drug candidate can be produced in the fastest, most efficient and economically friendly fashion, chemists perform innovative research from early-state development through the scaling-up process. Many analytical techniques including Nuclear Magnetic Resonance (NMR) spectroscopy are crucial in the drug discovery process and chemists use these tools daily to characterize reaction products every step of the way. Once a chemist’s reaction is complete and the desired product isolated, an NMR spectrum of the isolate is acquired. The chemist then interprets the spectrum by assigning the peaks in the spectrum to the unique sets of protons (1H), or other atoms (13C, 31P, 19F, 11B, etc.), in their desired molecule; corroborating they have made what they sought to make when the reaction was started.
The need to characterize molecules by NMR in the drug discovery process brings with it the potential large cost of obtaining a high-field instrument as well as the high maintenance costs associated with it. Many smaller organizations and institutions simply cannot afford these costs and circumvent them by sub-contracting out NMR work where by the researcher or institution rents/purchases NMR time from a nearby facility that has a high-field instrument. Alternatively, they package up and mail out their compounds for NMR analysis. Not only are these methods still relatively costly in terms of dollars per spectrum, but they also cause major delays in research. Some contract labs can take up to a week or two to return data to the requesting chemist.